lmmunogold staining of primary cultures of human brain microvessel endothelial cells demonstrated the presence of Factor Vm-related antigen within cytoplasmic vesicles in close association with the rough endoplasmic reticulum and Golgi apparatus. Immunoperoxidase staining, at the light microscopic level, revealed a similar granular, perinuclear staining. The morphology and location of these vesicular profiles indicate that they ace part of the rrans-Golgi region where terminal processing and short-term storage of Factor VIII-related antigen takes place. Weibel-palade bodies, specific storage organelles for von Willebrand factor in large vessel endothelium, were not observed in cerebral microves-se1 endothelium. The release of Factor VIII-related antigen from the cytoplasmic vesicles was influenced by some of the
Introduction
Factor VIII-related antigen (von Willebrand factor) is a large glycoprotein that facilitates adhesion of platelets to the subendothelial matrix after vascular injury. Endothelial cells of large and small blood vessels synthesize and release factor VIII-related antigen in vivo and in vitro (1.2) . Factor VIII-related antigen (FVII1R:Ag) has been detected by immunofluorescence staining in cultured endothelial cells isolated from various vascular beds (3) (4) (5) (6) (7) (8) (9) (10) and is widely considered the most specific marker for cells of endothelial origin. Recent immunohistochemical and biochemical studies indicate that part of the intracellular FVIIIR:Ag, in particular the large multimeric forms, are stored within Weibel-Palade bodies (12) (13) (14) . These are rodshaped, membrane-bound cytoplasmic organelles with characteristic parallel arrays of tubular structures first described in arterial endothelium (15) , and are found exclusively in endothelial cells. factors known to stimulate or inhibit the regulated pathway of secretion from Weibel-Palade bodies. Thus, stimulation of endothelial cells with calcium ionophore A23187 resulted in almost complete loss of staining, while addition of EGTA to the culture medium led to slight increase of intracellular pools of Factor VIII-related antigen. Pre-incubation of monolayers with interferon-? was associated with significant increase in the number of labeled vesicles, suggesting an additional role of this cytokine in the localized immune reaction within the central nervous system. ( J Hisrochem Cytochem 40:6896%, 1992) KEY WORDS: Cerebral endothelium; Primary cultures; Factor VIIIrelated antigen; Ca2' ionophore; EGTA; Interferon-y.
Although they are abundant in human large vessel endothelial cells, they are only infrequently present in capillary endothelium. Excretion of FVII1R:Ag by endothelial cells takes place via two pathways: a regulated pathway involving the stimulated release of large multimers from Weibel-Palade bodies, and a constitutive pathway leading to a continuous basal release of small multimers (16) (17) (18) . Weibel-Palade bodies are rarely found in endothelial cells lining the cerebral capillaries. Human brain microvessel endothelial cells in primary cultures synthesize FVIIIR:Ag, as indicated by their strongly positive staining for FVIIIR/vW AG by immunofluorescence and immunoperoxidase techniques (19). However, when examined ultrastructurally they are devoid of Weibel-Palade bodies. The present study investigates the distribution and fine structural localization of FV1IIR:Ag in primary cultures of microvascular endothelial cells derived from human brain. Using the immunogold-silver staining technique, we determined that FVI1IR:Ag is stored within membrane-bound cytoplasmic vesicles in close proximity to the rough endoplasmic reticulum and Golgi apparatus in a predominantly perinuclear region. Treatment of cultures with calcium ionophore A23187 resulted in rapid release of FVIIIR:Ag, while pre-incubation with interferon-? resulted in an increase in the number of labeled vesicles, presumably through inhibition of FVII1R:Ag release. Part of this work appeared in a preliminary report (20).
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Materials and Methods
Isolation and Culture of Human Brain Mim-I Endothelial Cells. Primary cultures of endothelial cells from human brain were established after isolation of microvessels from brains at autopsy by methods previously described by Dorovini-Zis et al. (19) . The endothelial origin of the cells was determined by their strongly positive, granular, perinuclear immunofluorescence for FVIII antigen and their positive reaction for Ulex Europueus I lectin as previously described (19) . Cells were seeded onto fibronectincoated plastic wells (Corning Plastics; Corning, NY) and were maintained in culture in minimum essential medium alpha (aMEM; Gibco, Burling ton, ON) supplemented with 10% horse plasma-derived serum (PDS: Hyclone Laboratories. Logan, UT). 25 mM Hepes. 10 mM sodium bicarbonate, heparin 100 pglml. endothelial cell growth supplement 20 mg/ml (all from Sigma; St Louis. MO) and penicillin 100 pglml. streptomycin 100 pg/ml, and amphotericin B 2.5 pglml (Gibco). at 37'C in a humidified 2.5% co2/97.5% air atmosphere. Culture medium was changed every other day. Endothelial cells reached confluency 6-8 days after plating. Cultures were used between the fifth and tenth day.
In Vitro Drug Treatment of Endothelial Cells. The effect of calcium ionophore A23187. ethyleneglycol-tetraacetic acid (EGTA). and interferon-y (IFN-y) on the release of NII1R:Ag was studied in confluent 8-day-old cultures. The cells were incubated with growth medium containing: (a) 10 pM Ca2+ ionophore A23187 (Sigma). diluted from a IO-mM stock dissolved in dimethylsulfoxide, for 10 min; (b) 1 mM EGTA (Sigma) for 10 min; and (c) 200 Ulml IF"-y (Collaborative Research; Bedford, MA) for 24 hr. At the end of the incubation period the cultures were washed with PBS and processed for immunoelcctron microscopy.
Antibodies. Mouse monoclonal antibody raised against human factor VI11 antigen (Cedarlane Laboratories; Hornby, ON) was used as the primary antibody and goat anti-mouse IgG coupled to 5-nm gold particles UanssenlCedarlane) as the secondary antibody for the ultrastructural lo-calization of FV1IIR:Ag. For the light microscopy immunoperouidasc staining, a rabbit antiscrum to factor VI11 antigen (Dakopatts; Santa Barbara, CA) was used as the primary antibody and goat anti-rabbit IgG conjugated with HRP (Jackson Immunoresearch Laboratories; West Grove, PA) as the secondary antibody.
Immunoperoxidase Staining. Cultures were fixed in cthano1:acetonc (1:l) for 7 min at 4'C. washed with Tris buffer, and incubated with a 1:lOO dilution of rabbit antiserum to factor VI11 antigen for 60 min at room temperature. After washing with Tris, the monolayers were incubated with a 1400 dilution of HRP-conjugated goat anti-rabbit IgG for 90 min at room temperature, washed with Tris and acetate buffers, incubated with aminoethyl-carbazol, and counterstained with hematoxylin. Controls consisted of cells incubated with normal rabbit serum.
Iinmunoelectron Microscopy. Endothelial monolayca were washed with PBS with 0.1 glliter CaC12 and fixed in freshly prepared pcriodate-lysine-paraformaldehyde (PLP) fixative (21) overnight at 4°C. After fixation the cultures were washed with PBS for 30 min and incubated in cold 10% sucrose solution in PBS for 4 hr. 15% sucrose for 4 hr. and 20% sucrose overnight. The cells were pcrmeabilized by incubation in 0.01-0.05% Triton X-100 (Sigma) in freshly prepared PLP for 10 min at room temperature. washed with PLP for 20 min. and then with 0.1 M glycine in PBS for 30 min. The monolayers were incubated with 5 % normal goat serum (NGS) in 0.1% BSA-Tris buffer (BSA-Tris) for 20 min and then with the primary antibody (mouse anti-human FVIII antigen) at 1:50 dilution with 1% NGS in BSA-Tris for 2.5 hr at room temperature. After washing in BSA-Tris. the cells were incubated with the secondary antibody (goat antimouse IgG) at 1:20 dilution in BSA-Tris for 1.5 hr at room temperature. Cultures were further fixed in 1% glutaraldehyde in PBS containing 0.2% tannic acid for 40 min at room temperature. washed in PBS, and post-fwcd in 0.5% osmium tetroxide ( 0 5 0 4 ) in PBS for 15 min. After post-fwation, the cells were washed in acetate buffer, block-stained in uranyl magnesium acetate overnight at 4'C, dehydrated through a graded series of methanol. and embedded in epon-araldite. Blocks cut from the embedded cultures were re-embedded for cross-sectioning. Thin sections were examined in a Philips EM400 without heavy metal staining.
Routine Electron Microscopy. Endothelial cell monolayers were washed in serum-free medium and fixed in 2.5% glutaraldehyde and 2 I paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.35) for 1 hr at 4°C. After washing with 0.2 M cacodylate buffer for 30 min. the cells were postfixed in 1% os04 in 0.1 M sodium cacodylate buffer for 1 hr at 4'C. blocked-stained with uranyl magnesium acetate overnight at 4'C. dehydrated, and embedded in epon-aralditc.
Results
Human brain microvessel endothelial cells in culture formed confluent contact-inhibiting monolayers composed of elongated, closely associated cells ( Figure 1A) . The immunoperoxidase reaction for FVIIIRAg revealed strongly positive, granular perinuclear staining of endothelial cells ( Figure 1B ). Rod-shaped structures indicative of Weibel-Palade bodies were not present in either the central or the peripheral cytoplasm.
Ultrastructurally, endothelial cells were elongated with overlapping processes. Junctional complexes with the characteristic pentalaminar configuration of tight junctions were present in areas of cell-to-cell contact. The cytoplasm was dense and contained prominent rough endoplasmic reticulum, frequent mitochondria, and scattered 8-10-nm intermediate filaments. Pinocytotic vesicles were infrequently seen. A constant finding in all cells examined was the presence of dilated cytoplasmic vesicles or vacuoles bound by a single smooth limiting membrane ( Figure 2 ). These vesicular structures were invariably located in the vicinity of the nucleus, in close association with the cisternae of the rough endoplasmic reticulum, and were absent from the most peripheral portions of the cytoplasm and the cell processes. They varied in size from 0.15-1.1 pm and they appeared empty or contained small amounts of amorphous material. Weibel-Palade bodies were not observed in any of the cultured endothelial cells examined.
In cultures stained for FVIIIRAg with the immunogold technique, 5-nm gold particles were distinctly localized within the vesicular profiles immediately adjacent to the rough endoplasmic reticulum ( Figure 3A ) and close to Golgi cisternae in sections where the Golgi apparatus was present ( Figure 3B ). The endoplasmic reticulum was largely unstained, with the rare exception of single isolated particles within its cisternae. Occasionally, labeled vesicles communicated directly with cisternae containing gold particles ( Figure  3C ). The number of labeled vesicles and the degree of labeling (number of gold particles per vesicle) varied among different cells. This is largely attributed to variable leakage of intracellular proteins after permeabilization or to insufficient permeabilization and penetration of individual endothelial cells by the antibodies. Low (0.01%) and high (0.05%) concentrations of Triton X-100 resulted in poor labeling, whereas a concentration of 0.03% was associated with frequent and denser labeling. There was no staining of the cytoplasmic membrane or the discontinuous basement membranelike material underlying the basal cell surface. The specific staining was eliminated in control cultures incubated with normal mouse IgG or carrier buffer ( Figure 3D) .
Treatment of the monolayers with 10 bm Ca2+ ionophore A23187 for 10 min resulted in almost complete loss of staining (Figure 4A ), whereas incubation with 1 mM EGTA for 10 min was associated with slightly increased numbers of labeled vesicles (Figure 4B) . When the monolayers were pre-incubated with 200 Ulml IFN-y for 24 hrs there was a significant increase in the number of immunostained vesicles over the untreated cultures ( Figure 4C ). To quantitate these findings, the number of labeled and unlabeled vesicles was counted in 100 cells in each group of treated and in untreated cultures. Figure 5 summarizes these results. The differences reflect variations in the percentage of immunostained vesicles. There was no appreciable difference in the number of gold particles per vesicle between treated and untreated cells. The difference in the number of labeled vesicles between controls and IFNy-treated endothelial cells was statistically significant (p = o.Ooo), whereas no significant difference was found between controls and EGTA-treated cultures @=0.21).
Immunocytochemical Localization of Factor VIIINon Willebrand Antigen in Human Brain Microvessel Endothelial Cells
Discussion
Human brain microvessel endothelial cells in primary culture synthesize FVIIIR: Ag as indicated by their positive granular perinuclear staining for FVII1R:Ag with the immunoperoxidase technique. By immunoelectron microscopy, FVI1IR:Ag is localized within cytoplasmic vesicles closely associated with the rough endoplasmic reticulum and Golgi apparatus in the perinuclear region. Treatment of endothelial cells with Ca2+ ionophore A23187 results in release of FVII1R:Ag from its stores, whereas pre-incubation with IFN-*I and EGTA leads to increase of intracellular pools of FVII1R:Ag.
Endothelial cells lining large vessels and arterioles synthesize and secrete FVII1R:Ag and store the newly synthesized glycoprotein within cytoplasmic organelles unique to these cells, known as Weibel-Palade bodies (12-14) . These rod-shaped structures are absent in primary cultures of microvessel endothelial cells derived from rat (22-24), mouse (25), and bovine cerebral cortex (26) and bovine retina (27), but have been reported present in endothelial cells derived from rat and bovine brain white matter (28). Weibel-Made bodies are extremely rare or absent in normal human cerebral capillaries (29,30). They have been observed in the orbital cortex of normal aged humans (31) and with increased frequency in certain brain tumors (30,32). Human cerebral microvessel endothelial cells in primary culture are similarly devoid of Weibel-Palade bodies. The granular perinuclear staining for FVIIIR:Ag with the immunoperoxidase technique corresponds to variably dilated vesicular profiles within which deposits of colloidal gold were observed ultrastructurally. The single limiting membrane of these vesicles is not decorated with ribosomes, and therefore it is unlikely that they represent dilated cisternae of rough endoplasmic reticulum. Their constant presence near the Golgi apparatus and the rough endoplasmic reticulum suggests that the immunolabeled vesicles belong to the polymorphous vacuoles that form part of the trans-most Golgi section (33). These frans-Golgi elements have been found to be part of the pathway of newly synthesized molecules (34). It is therefore likely that, after synthesis in the endoplasmic reticulum and extensive modification in the Golgi apparatus (35), the newly synthesized FVI1IR:Ag is transported to the tsans-Golgi polymorphous vesicles, where it is concentrated. In the absence of Weibel-Palade bodies in cerebral microvessel endothelial cells, these vesicular bodies most likely represent sites of short-term storage of FVII1R:Ag before release. Previous in vivo studies on the localization of FVI1IR:Ag in vascular endothelium of normal human extracerebral tissues and in one capillary hemangioma by immunoelectron microscopy demonstrated immunolabeling of endoplasmic reticulum and cytoplasmic vesicles and vacuoles, in addition to Weibel-Made bodies (14) . These vesicular profiles strongly resemble the ones observed in the present study. A similar localization of FVI1IR:Ag within cytoplasmic vesicles has been reported in endothelial cells lining the saphenous vein (2).
Large-vessel endothelial cells secrete the newly formed FVI1IR:Ag via two pathways (17J8). The regulated pathway involves release of the large multimeric forms of the glycoprotein from the specific storage organelles, the Weibel-Palade bodies. In vitro studies on the secretion of von Willebrand factor by umbilical vein endothelial cells indicate that this pathway is highly polarized and is dependent on an intact microtubular system, since microtubule-depolymerizing agents inhibit the regulated release (36). The majority of FVIIIR: Ag synthesized by endothelial cells is secreted constitutively in the form of small multimers. In contrast to the regulated pathway, constitutive release is not affected by microtubuledepolymerizing agents (37) and is not polarized. Since human brain microvessel endothelial cells do not store FVII1R:Ag in Weibel-Palade bodies, it is quite possible that they secrete the newly synthesized protein through the constitutive pathway only, with the Golgi-associated cytoplasmic vesicles serving as temporary storage pools after multimerization and before release.
A variety of stimuli can lead to increased release of FVI1IR:Ag from endothelial cells in vitro. Most of these factors stimulate the regulated pathway of secretion. Thus, treatment of endothelial cell monolayers with calcium ionophore A23187, thrombin, or phorbol-myristate-acetate results in release of the large multimeric forms of FV1IIR:Ag and a simultaneous disappearance of Weibel-Palade bodies from endothelial cells (17, 18, 36, 38) in association with a rise in the concentration of intracellular calcium. The effect of calcium ionophore was inhibited by EGTA in a dose-dependent manner (38). The basal secretion was apparently not affected by these treatments. In the present study, short pre-incubation of human brain microvessel endothelial cells with calcium ionophore led to a rapid reduction in the number of labeled cytoplasmic vesicles.
In contrast, addition of the calcium chelating agent EGTA to the culture medium resulted in slight increase in immunostained vacuoles, which was not statistically significant when compared with untreated cells. Loss of staining after calcium ionophore treatment may represent rapid release of FVI1IR:Ag from intracellular pools, although other mechanisms, such as antigen degradation after ionophore-mediated protease activation, cannot be ruled out. These findings indicate that at least some of the factors that stimulate the regulated pathway in large vessel endothelial cells similarly influence the release of FVI1IR:Ag from microvessel endothelium in the absence of Weibel-Palade bodies. Whether the FVI1IR:Ag secreted by cerebral small vessel endothelium is in the form of small or large multimers is presently unknown.
Incubation of endothelial cells with IFN-y for 24 hr resulted in a significant increase in the number of immunostained vesicles, suggesting that IFN-y interferes with the release and/or storage of FVI1IR:Ag. Recent studies on the effect of cytokines on the release of von Willebrand factor indicate that IFN-y decreases the constitutive and regulated release from cultured human umbilical vein endothelial cells reversibly and in a time-and dose-dependent manner (39). Although the exact mechanism of action is not presently known, it is possible that IFN-y exerts its effect by modifying the concentration of intracellular calcium. It has been recently demonstrated that IFN-y can activate the calcium-dependent pathway through activation of phospholipase C and can induce, in addition, a significant outflw of calcium ions from endothelial cells (40) . Inhibition of FVII1R:Ag release by IFN-y may be important, considering its pivotal role as mediator of the localized immune response in autoimmune diseases of the central nervous system.
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